AUB share price halted amid $880 million acquisition

Let's take a closer look.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The AUB Group Ltd (ASX: AUB) share price won't be trading till tomorrow as it undertakes a capital raise to fund an $880 million acquisition.

The insurance broker called for the trading halt and announced the takeover of Tysers. The London-based target is the sixth-largest wholesale broker in the Lloyd's marketplace with $3.6 billion in annual gross premiums.

The cash and scrip offer will be partly funded through a fully underwritten $350 million equity raising. The raising is made up of a $71 million share placement to institutional investors.

The balance will come via a 1-for-5.2 pro rata accelerated non-renounceable entitlement offer to existing shareholders.

changing asx share price from acqusition represented by man reaching out to touch acquisition sign

Image source: Getty Images

AUB shares on watch amid cash-scrip acquisition

Tysers owners, Odyssey Investment Partners, will be given $176 million worth of AUB shares as part of the transaction. The shares will be escrowed for 24-months.

AUB will also take on a new $675 million new debt facility to replace its existing $250 million facility. This will leave the company with $74 million in unused debt post the acquisition.

Strategic rationale

Management says that the acquisition is consistent with its strategy to expand its international offering, build economies of scale and capture more of the brokering value chain.

AUB added that Tysers will strengthen its competitive position. The target's specialist capabilities will enable AUB to design and offer market-leading products for AUB's broker and agency network and to enhance the ability to establish new agencies and secure Lloyd's binders.

AUB acquisition could hit $1.06 billion

The $880 million offer price could go up by another $176 million (earnout) if Tyser hits certain targets. But ignoring the earnout, the price tag for Tysers reflects a circa 12 times enterprise value to FY22 pro forma earnings before interest, tax, depreciation and amortisation (EBITDA).

However, if you include the forecast annual run-rate synergies from the merger of around $25 million, the multiple drops to around 9 times.

In other words, AUB believes the acquisition will lift its underlying earnings per share by 30% with the synergies.

The synergy assumptions are made up for cost savings and improving margins on current premiums to be fully realised after 18 months.

Sale of assets

In the wake of the acquisition, AUB intends to sell a 50% stake in Tysers' UK Retail division to PSC Insurance Group Ltd (ASX: PSI). PSC, a 50/50 joint venture partner with AUB, will purchase the asset on the same multiples and commercial terms.

"Lloyd's is the largest insurance market in the world. Tysers provides AUB Group the ability to access a diverse range of risks and insurance types for our clients and broker networks in Australia and New Zealand whilst also gaining the capability to accelerate the establishment of new agencies in these markets," said AUB chief executive Mike Emmett.

"Clive Buesnel, Tysers CEO, is a highly respected insurance executive in the Lloyds and London market, and we are delighted to welcome him and the Tysers team to the AUB family as we embark on a new chapter for both AUB Group and Tysers."  

Motley Fool contributor Brendon Lau has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended PSC Insurance Group. The Motley Fool Australia has recommended Austbrokers Holdings Limited and PSC Insurance Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Mergers & Acquisitions

Two men in suits face off against each other in a boing ring.
Mergers & Acquisitions

Which ASX 200 stock is lifting after a hostile takeover update?

Directors urge investors to reject the bid, that is below the current share price.

Read more »

Two miners examine things they have taken out the ground.
Mergers & Acquisitions

Big ASX 200 gold stock news! Regis Resources and Vault Minerals announce $11 billion merger

The ASX 200 gold stock sector is buzzing with the latest $11 billion merger news.

Read more »

Two miners wearing hard hats shake hands over a business deal.
Mergers & Acquisitions

Regis and Vault to combine, creating new ASX gold powerhouse

Regis Resources and Vault Minerals will merge to create Australia's third-largest gold producer, targeting over 700,000 ounces per year and…

Read more »

two men in business suits sit across from each other at a table with a chess board on it. Both hold their hands to their chins and look down in serious contemplation of their next move.
Mergers & Acquisitions

Which ASX 200 stock is slipping on a sharpened takeover bid?

IMF interest is getting more serious, with investors now reassessing.

Read more »

Ecstatic man giving a fist pump in an office hallway.
Mergers & Acquisitions

oOh!Media shares rocket 40% higher on takeover offer

A big takeover premium has reset expectations, but the market isn’t treating it as a done deal.

Read more »

A smiling market stall holder selling flowers holds out a payment machine to a customer who hovers her telephone over it to pay via Zip
Bank Shares

ANZ Bank shares push higher on acquisition news

Let's see what this big four bank is acquiring.

Read more »

Multiple ASX share investors take on one another in a tug of war in a high rise building.
Mergers & Acquisitions

Why the Atlas Arteria share price is rocketing 14% today

Atlas Arteria shares jump after a $6.9 billion takeover proposal lands.

Read more »

Two lab workers fist pump each other.
Mergers & Acquisitions

Why are Mesoblast shares jumping 8% today?

The biotech star has announced an exciting acquisition on Wednesday.

Read more »